Kennedy Capital Management’s TELA Bio TELA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q3
Sell
-381,919
Closed -$1.8M 735
2024
Q2
$1.8M Sell
381,919
-1,156
-0.3% -$6.09K 0.04% 523
2024
Q1
$2.17M Buy
383,075
+861
+0.2% +$5.68K 0.04% 504
2023
Q4
$2.53M Sell
382,214
-5,409
-1% -$31.3K 0.06% 442
2023
Q3
$3.1M Buy
387,623
+1,961
+0.5% +$18.2K 0.08% 381
2023
Q2
$3.91M Buy
385,662
+69,233
+22% +$708K 0.09% 344
2023
Q1
$3.37M Buy
316,429
+556
+0.2% +$6.13K 0.1% 331
2022
Q4
$3.63M Buy
315,873
+408
+0.1% +$3.65K 0.1% 333
2022
Q3
$2.69M Buy
+315,465
New +$2.62M 0.08% 375

Other funds holding TELA

Kennedy Capital Management's TELA Position: Q3 2024 in Review

Kennedy Capital Management sold out of TELA Bio (TELA) in Q3 2024, closing a stake of 381,919 shares — an estimated $1.8M sold.

Kennedy Capital Management first reported a position in TELA in Q3 2022 and held it in 8 quarters. The position peaked at $3.91M in Q2 2023. 49 funds tracked by Wall St. Rank hold TELA as of Q3 2024.

  • Kennedy Capital Management reported no remaining TELA Bio position as of Q3 2024 after selling out during the quarter.
  • Kennedy Capital Management sold 381,919 TELA Bio shares in Q3 2024, an estimated $1.8M.
  • Kennedy Capital Management first reported a position in TELA Bio in Q3 2022 and held it in 8 quarters.
  • Kennedy Capital Management's TELA Bio position peaked at $3.91M in Q2 2023.
  • 49 funds tracked by Wall St. Rank held TELA Bio as of Q3 2024.

Based on Kennedy Capital Management's 13F filing for Q3 2024, filed 14 Nov 2024.